Experimental Hematology & Oncology

Show Articles
Journal Properties
  • Number of Articles
    1
  • Abbreviation
    Exp Hematol Oncol
  • ISSN
    2162-3619
  • Publisher
    Springer Science and Business Media LLC
  • Indian UGC
  • DOAJ (latest)
Description
Experimental Hematology & Oncology is an open access, peer-reviewed journal dedicated to publishing cutting-edge research in basic, translational, and clinical hematology and oncology. With a broad scope encompassing experimental and clinical studies, the journal aims to advance the understanding and treatment of blood disorders and cancer. Its focus on bench-to-bedside research makes it a valuable resource for researchers, clinicians, and industry professionals in hematology and oncology. Key areas covered include hematologic malignancies, experimental therapeutics, cancer biology, and translational research. Indexed in major scientific databases, the journal provides a platform for disseminating innovative findings in areas such as tumor immunology, molecular oncology, and targeted therapy. The journal disseminates information on cancer, oncology, hematology, and tumor research. Submit your original research, reviews, and methodology articles to Experimental Hematology & Oncology to contribute to the advancement of knowledge in these critical fields. With its open access format, the journal ensures that research is freely accessible, promoting greater collaboration and innovation in the fight against blood disorders and cancer.